Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001883850-22-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-13 | 2022-11-08 | REGN | STAHL NEIL | EVP Research, Development | G - Gift | $0.00 | -330 | 52.5K | -0.6% | $0 | |
| 2022-12-13 | 2022-12-09 | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $753.28 | -466 | 52.0K | -0.9% | -$351.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-08 | G | D | 330 | $0.00 | 52,465 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-09 | F | D | 466 | $753.28 | 51,999 | D | — | — |